Hello, Fool! | Login | Signup | My Fool
Jul 8, 2008 11:54 PM ET | Site Changes | Help
Search: Tickers Company Names Players
A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.
View Ticker Page (AMLN)
Results 31 - 40 of 55 : 12345Next »
Recs
MudgieBoy (62.93) Submitted: 8/26/06 2:29 AM : Start Price: $45.15 AMLN Score: 40.51
Burning cash like it is weeds.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
mhheins (49.95) Submitted: 8/16/07 2:37 AM : Start Price: $49.29 AMLN Score: -38.24
the only pharma with a shot at curbing the obesity pandemic in this country
sewserious (96.24) Submitted: 7/25/07 1:25 PM : Start Price: $47.38 AMLN Score: -29.45
diabetes is going to be a long term epidemic in our society and amylin has the answer
vbarra (< 20) Submitted: 1/26/07 6:37 PM : Start Price: $38.83 AMLN Score: -22.50
Amln currently has gone lower due to the time it takes a new drug to realize potential. There is now overseas sale yet and when potential approval came people solid to take profits.OP S
maktop (< 20) Submitted: 1/26/07 12:08 PM : Start Price: $38.68 AMLN Score: -22.37
Diabetic drug that works very well and diabetes is at epidemic proportions in the population
popatop100 (< 20) Submitted: 1/20/07 12:33 PM : Start Price: $40.48 AMLN Score: -24.68
AMLN chart is perfect pennant
fatcityhk (22.45) Submitted: 1/03/07 11:55 PM : Start Price: $36.35 AMLN Score: -18.54
One drug WONDER???
dymwit (89.73) Submitted: 1/03/07 1:22 PM : Start Price: $36.58 AMLN Score: -18.03
takeover?
YancyG (< 20) Submitted: 12/19/06 5:31 PM : Start Price: $38.33 AMLN Score: 21.56
Byetta is a great drug. However with oral forms of similar drugs entering the market (eg Januvia) it will be difficult to retain market share with an injection.
zino2000 (< 20) Submitted: 11/15/06 11:00 PM : Start Price: $44.59 AMLN Score: -32.26
2 great drugs for diabetics... huge market...great pipeline for obesity... will be > $100 by 2009